Skip to main content

Table 3 Clinical outcomes

From: Severe pain-related adverse events of percutaneous dilatational tracheostomy performed by a neurointensivist compared with conventional surgical tracheostomy in neurocritically ill patients

 

PDT performed by a neurointensivist (n = 71)

Conventional surgical method (n = 85)

P value

Incidence of SAE — No. of patients (%)

30 (42.3)

57 (67.1)

0.002

Event of SAE — No. of events (%)

 Arrhythmia

13 (18.3)

36 (42.4)

0.001

  Tachycardia

13 (18.3)

34 (40.0)

 

  Bradycardia

0 (0)

3 (3.5)

 

 Hypertension

13 (18.3)

34 (40.0)

0.003

  Use of the antihypertensive drug during the procedure

7 (9.9)

11 (12.9)

0.728

 Ventilator distress

0 (0)

10 (11.8)

0.008

 Hypotension

1 (1.4)

5 (5.9)

0.303

 Desaturation

0 (0)

4 (4.7)

0.179

 Arrest

0 (0)

2 (2.4)

0.558

 Bradypnea

0 (0)

1 (1.2)

0.999

 Use of hyperosmolar agent during procedure

0 (0)

3 (3.5)

0.311

Duration of total SAE (min) — mean ± SD

3.4 ± 5.3

19.8 ± 23.0

< 0.001

Procedural data

 Initial success of tracheostomy — No. of patients (%)

71 (100)

81 (95.3)

0.179

 Procedure time (min) — mean ± SD

17.7 ± 9.2

42.2 ± 21.8

< 0.001

Outcomes

 ICU mortality — No. of patients (%)

2 (2.8)

1 (1.2)

0.187

 Hospital mortality — No. of patients (%)

6 (8.5)

9 (10.6)

0.651

 Length of stay in ICU (days) — mean ± SD

17.35 ± 13.2

18.11 ± 18.4

0.773

 Length of stay in hospital (days) — mean ± SD

78.74 ± 117.1

79.06 ± 136.2

0.988

  1. SAE severe pain-related adverse events, PDT Percutaneous dilatational tracheostomy, SD standard deviation, ICU intensive care unit